News
Opinion
FDA should judge drugs on what they do in real life, not just in companies’ clinical trialsUnder the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
1d
Clinical Trials Arena on MSNIsomorphic Labs prepares to launch trials for AI-designed drugsIn an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results